Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.165
+0.035 (3.10%)
Dec 3, 2024, 1:32 PM EST - Market open
Spero Therapeutics Employees
Spero Therapeutics had 46 employees as of December 31, 2023. The number of employees increased by 11 or 31.43% compared to the previous year.
Employees
46
Change (1Y)
11
Growth (1Y)
31.43%
Revenue / Employee
$2,314,239
Profits / Employee
$76,370
Market Cap
63.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Burning Rock Biotech | 786 |
InterCure | 270 |
Vor Biopharma | 168 |
AlloVir | 112 |
VolitionRx | 110 |
Boundless Bio | 72 |
Passage Bio | 58 |
Cellectar Biosciences | 20 |
SPRO News
- 18 days ago - Spero Therapeutics Announces Third Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 6 weeks ago - Spero Therapeutics Announces Presentation of SPR719 (Active Moiety of SPR720) In Vitro Data Demonstrating Low Propensity for the Development of Resistance at IDWeek 2024 - GlobeNewsWire
- 2 months ago - Spero Therapeutics Announces Publication of SPR720 Phase 1 Lung Exposure Data in Antimicrobial Agents and Chemotherapy - GlobeNewsWire
- 4 months ago - Spero Therapeutics, Inc. (SPRO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update - GlobeNewsWire
- 4 months ago - Spero Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on Monday, August 5, 2024 - GlobeNewsWire
- 5 months ago - Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 months ago - Spero Therapeutics to Participate in H.C. Wainwright Annual BioConnect Investor Conference - GlobeNewsWire